If you've started reading about growth hormone, you've run into two very different camps. One says the real thing is HGH: injectable human growth hormone, the actual hormone itself. The other points you toward a long list of peptides with names like sermorelin, ipamorelin, and CJC-1295. They're aiming at the same destination, but they take fundamentally different roads to get there. Understanding that difference is the single most useful thing you can learn before going any further.
What HGH and GH peptides have in common
Both are trying to raise growth hormone activity in your body, and through it, the downstream signal that does much of the actual work: a hormone called IGF-1 (insulin-like growth factor 1), which your liver produces in response to growth hormone. Growth hormone and IGF-1 influence how you build and repair tissue, how you sleep, how your body handles fat, and how your skin and connective tissue hold up over time. As you age, your natural output of growth hormone declines. Both approaches are attempts to push back against that decline. Where they part ways is in how.
How HGH works
HGH is recombinant human growth hormone, sometimes listed by its generic name, somatropin. It is a lab-made copy of the exact hormone your pituitary gland already produces. When you inject it, you are adding growth hormone directly to your bloodstream, bypassing your own glands entirely. The effect is immediate and not subtle: blood levels rise to wherever the dose puts them, which can be well above what your body would ever produce on its own. There is no negotiation with your biology. You set the level, and your body responds to it.
How GH peptides work
GH peptides don't contain any growth hormone at all. Instead, they are signaling molecules that travel to your pituitary gland and ask it to release more of its own growth hormone. They fall into two families. GHRH analogs (growth hormone releasing hormone) like sermorelin and CJC-1295 mimic the natural "release now" signal your hypothalamus sends. Ghrelin mimetics, also called secretagogues, like ipamorelin and the GHRP family, work through a second, complementary doorway to amplify that same release. Either way, the hormone that ends up in your blood is your own, produced by your own gland, in the natural rhythm your body uses.
Key differences
The most important difference is the safety valve. Your body regulates its own growth hormone through a feedback loop: when levels get high enough, a hormone called somatostatin steps in and tells the pituitary to ease off. GH peptides work within that loop. You can encourage your pituitary to release more, but your body retains the ability to say "that's enough." HGH overrides the loop completely. Because the hormone is coming from outside, your own regulation has no say in the matter, which is exactly why supraphysiologic levels (higher than your body would naturally reach) are possible, and why side effects tend to scale with dose.
That leads to the second difference: shutdown. When you supply growth hormone from outside for long enough, your pituitary notices it isn't needed and quiets its own production. GH peptides do the opposite. They keep your pituitary working, which is part of why they're often described as the gentler, more sustainable approach.
Rhythm matters too. Healthy growth hormone release happens in pulses, mostly at night during deep sleep, not as a steady flat level. GH peptides preserve that pulsatile pattern because they're amplifying a natural process. HGH replaces the pulses with whatever curve the injection produces. Researchers think the pulse pattern itself carries biological meaning, so this isn't a trivial distinction.
Then there's potency and predictability. HGH is the stronger lever by a wide margin. If the goal is a large, reliable increase in growth hormone, nothing a peptide does will match injecting the hormone directly. The peptides produce a more modest, more variable bump that depends on how responsive your own pituitary still is. Finally, the regulatory picture differs sharply: HGH is a tightly controlled prescription drug in the United States, legal to prescribe only for specific approved conditions, while the GH peptides are sold as research compounds and are not approved for human use.
| HGH (somatropin) | GH peptides | |
|---|---|---|
| What it is | The hormone itself | A signal to make your own |
| Source of GH | External, injected | Your own pituitary |
| Feedback safety valve | Overridden | Preserved |
| Natural pulse rhythm | Replaced | Preserved |
| Potency | Strong, predictable | Milder, variable |
| Pituitary shutdown risk | Yes, over time | No, keeps it active |
| Regulatory status | Controlled prescription drug | Research compound, not approved |
Bottom line
HGH is the maximum-strength option, and it comes with maximum-strength considerations. It makes the most sense inside a clinical setting, under a prescriber, for someone whose own production is genuinely deficient and who is being monitored for the side effects that come with overriding the body's own controls: fluid retention, joint discomfort, effects on blood sugar, and more. It is not a casual choice, and it is not legally a casual purchase.
GH peptides appeal to people who want to nudge a declining system rather than replace it, and who value keeping their own regulation intact. They are gentler, more forgiving of mistakes because of that built-in ceiling, and the realistic place most people actually start when they're curious about growth hormone support. The trade-off is honest: a smaller, less certain effect that depends on a pituitary that still works. Which family of peptide to begin with is its own decision, and one worth understanding before you buy anything.
Where to go from here
If GH peptides are the direction you're leaning, the next question is which one to start with. Two of the most common first choices are compared head to head in Ipamorelin vs. Sermorelin, and the popular pairing of a GHRH analog with a secretagogue is explained in CJC-1295 vs. Sermorelin. To compare per-milligram pricing across vendors before you commit to anything, the Peptide Price Lab tool tracks the research market in one place.